BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28108746)

  • 1. Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes.
    Casacuberta-Serra S; Parés M; Golbano A; Coves E; Espejo C; Barquinero J
    Immunol Cell Biol; 2017 Jul; 95(6):538-548. PubMed ID: 28108746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
    Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
    Front Immunol; 2019; 10():183. PubMed ID: 30863394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1d is a novel cell-surface marker for human monocytic myeloid-derived suppressor cells with T cell suppression activity in peripheral blood after allogeneic hematopoietic stem cell transplantation.
    An B; Lim JY; Jeong S; Shin DM; Choi EY; Min CK; Hong SH
    Biochem Biophys Res Commun; 2018 Jan; 495(1):519-525. PubMed ID: 29108995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioned media from the renal cell carcinoma cell line 786.O drives human blood monocytes to a monocytic myeloid-derived suppressor cell phenotype.
    Okada SL; Simmons RM; Franke-Welch S; Nguyen TH; Korman AJ; Dillon SR; Gilbertson DG
    Cell Immunol; 2018 Jan; 323():49-58. PubMed ID: 29103587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
    Höchst B; Schildberg FA; Sauerborn P; Gäbel YA; Gevensleben H; Goltz D; Heukamp LC; Türler A; Ballmaier M; Gieseke F; Müller I; Kalff J; Kurts C; Knolle PA; Diehl L
    J Hepatol; 2013 Sep; 59(3):528-35. PubMed ID: 23665041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated NKT cells facilitated functional switch of myeloid-derived suppressor cells at inflammation sites in fulminant hepatitis mice.
    Wu D; Shi Y; Wang C; Chen H; Liu Q; Liu J; Zhang L; Wu Y; Xia D
    Immunobiology; 2017 Feb; 222(2):440-449. PubMed ID: 27523745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
    Lee CR; Lee W; Cho SK; Park SG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.
    Gonzalez-Junca A; Driscoll KE; Pellicciotta I; Du S; Lo CH; Roy R; Parry R; Tenvooren I; Marquez DM; Spitzer MH; Barcellos-Hoff MH
    Cancer Immunol Res; 2019 Feb; 7(2):306-320. PubMed ID: 30538091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].
    Su Z; Zhang Y; Ni P; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1362-1365. PubMed ID: 27667463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
    Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-Versus-Host Disease Prevention by
    Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
    Front Immunol; 2021; 12():754316. PubMed ID: 34721430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine CMV induces type 1 IFN that impairs differentiation of MDSCs critical for transplantation tolerance.
    Dangi A; Zhang L; Zhang X; Luo X
    Blood Adv; 2018 Mar; 2(6):669-680. PubMed ID: 29563123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
    Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y
    Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment.
    Sceneay J; Griessinger CM; Hoffmann SHL; Wen SW; Wong CSF; Krumeich S; Kneilling M; Pichler BJ; Möller A
    PLoS One; 2018; 13(4):e0196040. PubMed ID: 29677215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow.
    Roussel M; Ferrell PB; Greenplate AR; Lhomme F; Le Gallou S; Diggins KE; Johnson DB; Irish JM
    J Leukoc Biol; 2017 Aug; 102(2):437-447. PubMed ID: 28400539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
    Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
    Front Immunol; 2021; 12():606024. PubMed ID: 33986739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.
    Iacobaeus E; Douagi I; Jitschin R; Marcusson-Ståhl M; Andrén AT; Gavin C; Lefsihane K; Davies LC; Mougiakakos D; Kadri N; Le Blanc K
    Immunol Cell Biol; 2018 Sep; 96(8):820-830. PubMed ID: 29569304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.